TREA

98361283

Follow

Information

  • Trademark
  • 98361283
  • Serial Number
    98361283
  • Filing Date
    January 17, 2024
    a year ago
  • Transaction Date
    March 05, 2025
    5 days ago
  • Status Date
    February 14, 2025
    24 days ago
  • Published for Opposition Date
    March 11, 2025
    15 hours from now
  • Location Date
    February 14, 2025
    24 days ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CHUO, EMILY
  • Attorney Docket Number
    NEUB 2401456
    Attorney Name
    Allison Strickland Ricketts
  • Owners
Information
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of two same size arches with rounded end points. The front arch begins to the left of the back arch and covers a portion of the back arch.
  • GS0051: pharmaceutical preparations for human use for the treatment of adrenal insufficiency; pharmaceutical preparations for human use for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
  • GS0421: providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
Case File Event Statements
  • 1/17/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/5/2024 - 10 months ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 5/5/2024 - 10 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/30/2024 - 9 months ago
    6 - PRIORITY ACTION E-MAILED Type: GPRA
  • 5/30/2024 - 9 months ago
    5 - PRIORITY ACTION WRITTEN Type: CPRA
  • 5/22/2024 - 9 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/30/2024 - 9 months ago
    7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 7/31/2024 - 7 months ago
    8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 8/15/2024 - 6 months ago
    11 - PRIORITY ACTION E-MAILED Type: GPRA
  • 8/15/2024 - 6 months ago
    10 - PRIORITY ACTION WRITTEN Type: CPRA
  • 8/27/2024 - 6 months ago
    13 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 8/27/2024 - 6 months ago
    14 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 2/7/2025 - a month ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/7/2025 - a month ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/7/2025 - a month ago
    15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/31/2024 - 7 months ago
    9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 8/15/2024 - 6 months ago
    12 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 2/12/2025 - 26 days ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/14/2025 - 24 days ago
    20 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 2/14/2025 - 24 days ago
    19 - ASSIGNED TO LIE Type: ALIE
  • 3/5/2025 - 5 days ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP